| Malignant progressors (n = 19) | Nonprogressors (n = 39) | P-value |
---|---|---|---|
Clinical characteristics | |||
 Sex, male | 9 (47.4%) | 22 (56.4%) | 0.517 |
 Age | 65 ± 19 | 69 ± 13 | 0.407 |
 Hypertension | 15 (75.0%) | 24 (60.0%) | 0.251 |
 Diabetes mellitus | 8 (40.0%) | 10 (25.0%) | 0.232 |
 Onset to door (min) | 195 ± 240 | 173 ± 182 | 0.511 |
 Hypothermia | 10 (52.6%) | 21 (53.8%) | 0.931 |
 Thrombolysis | 12 (63.2%) | 29 (74.4%) | 0.379 |
 Endovascular treatment | 19 (100.0%) | 29 (74.4%) | 0.015 |
 Successful reperfusion | 11 (57.9%) | 22 (56.4%) | 0.915 |
 Outcomes (3 month mRS) |  |  | 0.014 |
  0 | 0 (0.0%) | 2 (5.1%) |  |
  1 | 0 (0.0%) | 2 (5.1%) |  |
  2 | 0 (0.0%) | 5 (12.8%) |  |
  3 | 1 (5.3%) | 4 (10.3%) |  |
  4 | 2 (10.5%) | 10 (25.6%) |  |
  5 | 3 (15.8%) | 9 (23.1) |  |
  6 | 13 (68.4%) | 7 (17.9%) |  |
CTbaseline | |||
 CT angiography occlusion |  |  | 0.015 |
  Complex T | 10 (52.6%) | 6 (15.4%) |  |
  Simple T | 4 (21.1%) | 11 (28.2%) |  |
  MCA M1 | 3 (15.8%) | 14 (35.9%) |  |
  Tandem | 0 (0.0%) | 7 (17.9%) |  |
  Proximal ICA | 1 (5.3%) | 0 (0.0%) |  |
  Dissection | 1 (5.3%) | 1 (2.6%) |  |
 Initial DWI volume (ml) | 237 ± 109 | 144 ± 43 | 0.002 |
 ONSD (mm) | 5.17 ± 0.55 | 5.37 ± 0.63 | 0.233 |
 ONSD/ETD ratio | 22.84 ± 2.33% | 23.60 ± 2.83% | 0.316 |
 MLS (mm) | 0.44 ± 0.78 | 0.37 ± 0.95 | 0.789 |